Autism Biomarker Consortium for Clinical Trials (ABC-CT): Follow-up Study

CompletedOBSERVATIONAL
Enrollment

265

Participants

Timeline

Start Date

April 9, 2021

Primary Completion Date

August 11, 2022

Study Completion Date

August 11, 2022

Conditions
Autism Spectrum Disorder
Trial Locations (1)

06512

Yale University Child Study Center, New Haven

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Boston Children's Hospital

OTHER

collaborator

Duke University

OTHER

collaborator

University of California, Los Angeles

OTHER

collaborator

University of Washington

OTHER

collaborator

Food and Drug Administration (FDA)

FED

collaborator

National Institute of Mental Health (NIMH)

NIH

lead

Yale University

OTHER

NCT04841525 - Autism Biomarker Consortium for Clinical Trials (ABC-CT): Follow-up Study | Biotech Hunter | Biotech Hunter